Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 52.7M | 53.4M | 65.5M | 47.6M | 38.4M | 62.9M | 54.7M | 34.2M | 21.1M | 9.2M | 4.4M | 3.5M | 0 | 34.9M | 8.4M | 6.6M | 388,000 |
| Gross Profit | 25.8M | 29.1M | 42.5M | 28.0M | 22.0M | 52.0M | 43.8M | 24.9M | 4.0M | 801,000 | 3.6M | 2.9M | 0 | 26.3M | 1.4M | 6.9M | -3.2M |
| Profitability | |||||||||||||||||
| Operating Income | -5.5M | 3.9M | 10.5M | -13.0M | -20.5M | 2.7M | -10.7M | -19.3M | -34.5M | -33.2M | -23.7M | -28.6M | -34.1M | -12.2M | -36.5M | -30.0M | -32.0M |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | -6.6M | 2.9M | 8.3M | -14.9M | -27.6M | -6.5M | -18.3M | -26.5M | -83.4M | -29.4M | 58.0M | -29.9M | -27.8M | -11.6M | -36.5M | -29.0M | -31.4M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 79M | 81M | 82M | 48M | 44M | 29M | 15M | 15M | 144M | 124M | 100M | 94M | 94M | 93M | 86M | 81M | — |
Protalix Biotherapeutics Inc. Income Statement — FAQ
Protalix Biotherapeutics Inc. (PLX) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLX's income statement history?
The chart and table above show Protalix Biotherapeutics Inc.'s income statement by year and by quarter, including the growth rate.